179 related articles for article (PubMed ID: 19737975)
1. Functional analysis of secreted caveolin-1 in mouse models of prostate cancer progression.
Watanabe M; Yang G; Cao G; Tahir SA; Naruishi K; Tabata K; Fattah EA; Rajagopalan K; Timme TL; Park S; Kurosaka S; Edamura K; Tanimoto R; Demayo FJ; Goltsov AA; Thompson TC
Mol Cancer Res; 2009 Sep; 7(9):1446-55. PubMed ID: 19737975
[TBL] [Abstract][Full Text] [Related]
2. Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer.
Yang G; Goltsov AA; Ren C; Kurosaka S; Edamura K; Logothetis R; DeMayo FJ; Troncoso P; Blando J; DiGiovanni J; Thompson TC
Mol Cancer Res; 2012 Feb; 10(2):218-29. PubMed ID: 22144662
[TBL] [Abstract][Full Text] [Related]
3. An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation.
Di Vizio D; Morello M; Sotgia F; Pestell RG; Freeman MR; Lisanti MP
Cell Cycle; 2009 Aug; 8(15):2420-4. PubMed ID: 19556867
[TBL] [Abstract][Full Text] [Related]
4. Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cells.
Tahir SA; Park S; Thompson TC
Cancer Biol Ther; 2009 Dec; 8(23):2286-96. PubMed ID: 19923922
[TBL] [Abstract][Full Text] [Related]
5. Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression.
Ayala G; Morello M; Frolov A; You S; Li R; Rosati F; Bartolucci G; Danza G; Adam RM; Thompson TC; Lisanti MP; Freeman MR; Vizio DD
J Pathol; 2013 Sep; 231(1):77-87. PubMed ID: 23729330
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice.
Williams TM; Hassan GS; Li J; Cohen AW; Medina F; Frank PG; Pestell RG; Di Vizio D; Loda M; Lisanti MP
J Biol Chem; 2005 Jul; 280(26):25134-45. PubMed ID: 15802273
[TBL] [Abstract][Full Text] [Related]
7. Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancer.
Karantanos T; Karanika S; Wang J; Yang G; Dobashi M; Park S; Ren C; Li L; Basourakos SP; Hoang A; Efstathiou E; Wang X; Troncoso P; Titus M; Broom B; Kim J; Corn PG; Logothetis CJ; Thompson TC
Oncotarget; 2016 Jul; 7(29):46321-46334. PubMed ID: 27331874
[TBL] [Abstract][Full Text] [Related]
8. Caveolin-1 overexpression enhances androgen-dependent growth and proliferation in the mouse prostate.
Bryant KG; Camacho J; Jasmin JF; Wang C; Addya S; Casimiro MC; Fortina P; Balasubramaniam S; Knudsen KE; Schwarting R; Lisanti MP; Mercier I
Int J Biochem Cell Biol; 2011 Sep; 43(9):1318-29. PubMed ID: 21601007
[TBL] [Abstract][Full Text] [Related]
9. The role of caveolin-1 in prostate cancer: clinical implications.
Thompson TC; Tahir SA; Li L; Watanabe M; Naruishi K; Yang G; Kadmon D; Logothetis CJ; Troncoso P; Ren C; Goltsov A; Park S
Prostate Cancer Prostatic Dis; 2010 Mar; 13(1):6-11. PubMed ID: 19581923
[TBL] [Abstract][Full Text] [Related]
10. Serum caveolin-1, a biomarker of drug response and therapeutic target in prostate cancer models.
Tahir SA; Kurosaka S; Tanimoto R; Goltsov AA; Park S; Thompson TC
Cancer Biol Ther; 2013 Feb; 14(2):117-26. PubMed ID: 23114714
[TBL] [Abstract][Full Text] [Related]
11. Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancer.
Tahir SA; Yang G; Goltsov AA; Watanabe M; Tabata K; Addai J; Fattah el MA; Kadmon D; Thompson TC
Cancer Res; 2008 Feb; 68(3):731-9. PubMed ID: 18245473
[TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells.
Li L; Yang G; Ebara S; Satoh T; Nasu Y; Timme TL; Ren C; Wang J; Tahir SA; Thompson TC
Cancer Res; 2001 Jun; 61(11):4386-92. PubMed ID: 11389065
[TBL] [Abstract][Full Text] [Related]
13. MMTV promoter-regulated caveolin-1 overexpression yields defective parenchymal epithelia in multiple exocrine organs of transgenic mice.
Yang G; Park S; Cao G; Goltsov A; Ren C; Truong LD; Demayo F; Thompson TC
Exp Mol Pathol; 2010 Aug; 89(1):9-19. PubMed ID: 20399205
[TBL] [Abstract][Full Text] [Related]
14. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
[TBL] [Abstract][Full Text] [Related]
15. Caveolin-1 is required for the upregulation of fatty acid synthase (FASN), a tumor promoter, during prostate cancer progression.
Di Vizio D; Sotgia F; Williams TM; Hassan GS; Capozza F; Frank PG; Pestell RG; Loda M; Freeman MR; Lisanti MP
Cancer Biol Ther; 2007 Aug; 6(8):1263-8. PubMed ID: 17786030
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A.
Li L; Ren CH; Tahir SA; Ren C; Thompson TC
Mol Cell Biol; 2003 Dec; 23(24):9389-404. PubMed ID: 14645548
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-1 promotes autoregulatory, Akt-mediated induction of cancer-promoting growth factors in prostate cancer cells.
Li L; Ren C; Yang G; Goltsov AA; Tabata K; Thompson TC
Mol Cancer Res; 2009 Nov; 7(11):1781-91. PubMed ID: 19903767
[TBL] [Abstract][Full Text] [Related]
18. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.
Kasper S; Sheppard PC; Yan Y; Pettigrew N; Borowsky AD; Prins GS; Dodd JG; Duckworth ML; Matusik RJ
Lab Invest; 1998 Mar; 78(3):319-33. PubMed ID: 9520945
[TBL] [Abstract][Full Text] [Related]
19. Caveolin-1 secreting LNCaP cells induce tumor growth of caveolin-1 negative LNCaP cells in vivo.
Bartz R; Zhou J; Hsieh JT; Ying Y; Li W; Liu P
Int J Cancer; 2008 Feb; 122(3):520-5. PubMed ID: 17943731
[TBL] [Abstract][Full Text] [Related]
20. Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer.
Tahir SA; Ren C; Timme TL; Gdor Y; Hoogeveen R; Morrisett JD; Frolov A; Ayala G; Wheeler TM; Thompson TC
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3653-9. PubMed ID: 14506154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
